美股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

罗氏控股

44.91

+0.24000.54%

盘后：44.910.00000.00%16:13 EDT

成交量：148.44万

成交额：6,676.26万

市值：2,861.22亿

市盈率：28.96

高：45.21

开：44.54

低：44.50

收：44.67

52周最高：45.94

52周最低：34.10

股本：63.71亿

流通股本：63.71亿

量比：1.09

换手率：0.02%

股息：1.53

股息率：3.40%

每股收益(TTM):1.55

每股收益(LYR):2.14

净资产收益率：31.32%

总资产收益率：13.30%

市净率：7.92

市盈率(LYR):21.02

数据加载中...

总览公司新闻公告

概念

no data

没有相关数据

资金流向

资金流入：

资金流出：

新闻

周三值得关注的股票：耐克、Lithium Americas Corp.、ARM Holdings、西方石油

罗氏(RHHBY.US)减肥药CT-388明年推进后期试验挑战礼来、诺和诺德主导地位

罗氏(RHHBY.US)乳腺癌新药三期试验达主要终点延长晚期患者无进展生存期

罗氏(RHHBY.US)将以高达35亿美元收购89bio(ETNB.US) 加码减肥药市场

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/RHHBY"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"RHHBY","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RHHBY\",,,,,undefined,":{"symbol":"RHHBY","market":"US","secType":"STK","nameCN":"罗氏控股","latestPrice":44.91,"timestamp":1760731200000,"preClose":44.67,"halted":0,"volume":1484375,"hourTrading":{"tag":"盘后","latestPrice":44.91,"preClose":44.91,"latestTime":"16:13 EDT","volume":2124,"amount":95577.23999999999,"timestamp":1760732012878},"delay":15,"floatShares":6371000000,"shares":6371000000,"eps":1.550894,"marketStatus":"盘后交易","change":0.24,"latestTime":"10-17 16:00:00 EDT 延时","open":44.54,"high":45.21,"low":44.5,"amount":66762585.9375,"amplitude":0.015894,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":1.550894,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1760745600000},"marketStatusCode":4,"adr":0,"adrRate":0.125,"exchange":"OTCQX","adjPreClose":44.67,"volumeRatio":1.089847},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RHHBY\",,,,,undefined,":{"symbol":"RHHBY","floatShares":6371000000,"roa":"13.30%","roe":"31.32%","lyrEps":2.136203,"volumeRatio":1.089847,"shares":6371000000,"dividePrice":1.527848,"high":45.21,"amplitude":0.015894,"preClose":44.67,"low":44.5,"week52Low":34.103,"pbRate":"7.92","psRate":"3.58","week52High":45.94,"institutionHeld":0.0396,"latestPrice":44.91,"eps":1.550894,"divideRate":0.03402,"volume":1484375,"delay":15,"ttmEps":1.550894,"open":44.54,"prevYearClose":34.88,"prevWeekClose":45.66,"prevMonthClose":41.81,"prevQuarterClose":41.81,"fiveDayClose":45.66,"twentyDayClose":41.79,"sixtyDayClose":41.44},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/RHHBY\",params:#limit:5,,,undefined,":[{"date":"2025-03-28","symbol":"RHHBY","amount":0.855932,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-28","defaultRemindTime":1743168600000,"name":"罗氏控股","lastCurrency":null,"lastExecuteDate":null,"recordDate":null,"payableDate":"2025-03-28","currency":"USD","dateTimestamp":1743134400000,"payDate":null},{"date":"2024-07-25","symbol":"RHHBY","type":"earning","reportTimeType":"","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1721894400000,"name":null,"time":"","dateTimestamp":1721880000000,"actualEps":null},{"date":"2024-03-14","symbol":"RHHBY","amount":0.8751559,"announcedDate":null,"type":"dividend","market":"US","newRecordDate":"2024-03-15","defaultRemindTime":1710423000000,"name":"罗氏控股","recordDate":null,"payableDate":"2024-03-15","currency":"USD","dateTimestamp":1710388800000,"payDate":null},{"market":"US","date":"2024-02-01","symbol":"RHHBY","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1706763600000,"reportTimeType":"","actualEps":null},{"date":"2023-07-27","symbol":"RHHBY","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1690444800000,"name":null,"time":"盘前","dateTimestamp":1690430400000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"RHHBY\",market:\"US\",,,undefined,":[{"executeDate":"2016-03-02","recordDate":"2016-03-04","paymentDate":"2016-04-22","value":0.837655,"currency":"USD"},{"executeDate":"2019-03-07","recordDate":"2019-03-08","paymentDate":"2019-03-18","value":0.691071,"currency":"USD"},{"executeDate":"2020-03-19","recordDate":"2020-03-20","paymentDate":"2020-03-30","value":0.7280819,"currency":"USD"},{"executeDate":"2021-03-18","recordDate":"2021-03-19","paymentDate":"2021-03-29","value":0.8108518,"currency":"USD"},{"executeDate":"2022-03-17","recordDate":"2022-03-18","paymentDate":"2022-03-28","value":1.2649619,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"RHHBY\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.125,"buy":0.375,"hold":0.375,"sell":0.125,"strongSell":0,"meanLabel":"BUY","meanPercent":0.375,"analysts":8,"updateTime":1759550400000},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"RHHBY\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1190959042","title":"周三值得关注的股票：耐克、Lithium Americas Corp.、ARM Holdings、西方石油","url":"https://stock-news.laohu8.com/highlight/detail?id=1190959042","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1190959042?lang=zh_cn&edition=fundamental","pubTime":"2025-10-01 17:07","pubTimestamp":1759309631,"startTime":"0","endTime":"0","summary":"Lithium Americas Corp.：美国政府周二表示将持有这家加拿大公司及其内华达州采矿项目各5%的股份。股价在盘前交易中大涨约三分之一。耐克：这家零售商上季度销售出现意外增长，但将本财年关税成本预测上调至15亿美元。ARM Holdings：美国法院驳回了这家芯片设计公司对高通旗下子公司违反许可协议的指控。ARM Holdings股价在开盘前下跌约2%。这一消息周二也推高了美国制药股。西方石油股价在盘前交易中上涨超过1%。Acuity Brands Inc、Cal-Maine Foods和康尼格拉预计将在开盘前公布业绩。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1917777945.USD","IE0034235303.USD","IE00B19Z3B42.SGD","LU0980610538.SGD","RHHBY","BK4604","IE00BKDWB100.SGD","BK4519","BK4559","LU1974910355.USD","SG9999015978.USD","IE00B1XK9C88.USD","LU0130102774.USD","LU0109394709.USD","LU0787776722.HKD","LU2098885051.SGD","LU0029864427.USD","LU0868494708.USD","BK4612","IE00B19Z3581.USD","BK4532","BK4168","BK4527","AYI","LU1201861249.SGD","IE00BVYPNP33.GBP","LU1035775433.USD","CAG","BK4605","LU0823411888.USD","LU0310800379.SGD","LU2168564149.EUR","GB00BDT5M118.USD","LU2462157665.USD","LU1084165304.USD","LU1119994496.HKD","BK4176","IE00BVYPNQ40.USD","QCOM","IE00BWXC8680.SGD","IE00B3S45H60.SGD","BK4550","LU0640476718.USD","IE00BKVL7J92.USD","LU0683600562.USD","LU1093756168.USD","BK4543","BK4212","SG9999001424.SGD","BK4573","LU2236285917.USD","LU1366333091.USD","LU0203345920.USD","LU1093756325.SGD","LU1829250122.USD","BK4566","IE00BK4W5L77.USD","LU0971096721.USD","BK4568","BK4609","LU2456880835.USD","IE00BMPRXQ63.HKD","LU0786609619.USD","BK4581","LU2168564222.USD","LU0251142724.SGD","LU0256863811.USD","LU0149725797.USD","BK4007","OXY","BK4201","BK4533","LU0648001328.SGD","LU0417517546.SGD","IE000M9KFDE8.USD","ARM","LU0210528500.USD","SG9999015952.SGD","LU1363072403.SGD","BK4599","IE00BZ1G4Q59.USD","BK4512","LU0079474960.USD","LU0320765992.SGD","AZN","BK4524","LU0053666078.USD","LU2168563687.JPY","LU0048573561.USD","LU1069344957.HKD","IE0002270589.USD","LU1823568750.SGD","SG9999015986.USD","BK4534","IE00BSNM7G36.USD","LU2168564495.EUR","LU0868494617.USD","LU0348723411.USD","LU1280957306.USD","CALM","BK4585","LU0708994859.HKD","LU1074936037.SGD","IE00BMPRXN33.USD","AES","BK4105","LU0889565916.HKD","LU1303367103.USD","LU1914381329.SGD","LU0081259029.USD","LU0234572021.USD","LU0154236417.USD","BK4575","BK4558","BK4579","IE00BGHQDM52.EUR","IE00BYQQ9H92.USD","BK4545","SG9999015945.SGD","LU1571399168.USD","LU2417539215.USD","IE00BK4W5M84.HKD","03165","NKE","LU0742534661.SGD","LU2487616109.SGD","LU0157215616.USD","BK4588","IE00BFXG0V08.USD","LU2106854487.HKD","LU0203347892.USD","LU0251131958.USD","LU0234570918.USD","BK4554","IE00B775SV38.USD","IE00BMPRXR70.SGD","LU1261432733.SGD","BRK.B","NVO","LU0128525929.USD","BK4141","BK4598","BK4515","LU0061475181.USD","IE00B7SZLL34.SGD","LU0054578231.USD","BK4096","LU0170899867.USD","IE00BJLML261.HKD","LU2168564065.EUR","LU1046421795.USD","LAC","LU1267930573.SGD","LU2023250504.SGD","LU2247934214.USD","LU0942090050.USD","BK4561","BK4146"],"gpt_icon":1},{"id":"2569788388","title":"罗氏(RHHBY.US)减肥药CT-388明年推进后期试验 挑战礼来、诺和诺德主导地位","url":"https://stock-news.laohu8.com/highlight/detail?id=2569788388","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2569788388?lang=zh_cn&edition=fundamental","pubTime":"2025-09-22 17:31","pubTimestamp":1758533496,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，罗氏计划明年将实验性减肥药CT-388推进至后期试验阶段，以期在减肥药市场中挑战礼来、诺和诺德等头部企业。这款药物去年因早期研究披露的恶心、呕吐等副作用数据引发股价大幅下挫，但罗氏随后强调其副作用发生率与竞品相近，费用水平亦无显著差异。当前肥胖症市场由礼来和诺和诺德主导，预计到2030年年销售额将突破1000亿美元。截至上周五，罗氏股价收涨1.46%，年内累计涨幅约5.4%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"c8c015636e69da2c01039595706c31dc","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1347947.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"罗氏(RHHBY.US)减肥药CT-388明年推进后期试验 挑战礼来、诺和诺德主导地位","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1069344957.HKD","SG9999014898.SGD","LU1267930730.SGD","LU2471134879.HKD","LU1366192091.USD","LU0823434740.USD","LU2264538146.SGD","LU1868836591.USD","LU2236285917.USD","LU0353189680.USD","LU0203201768.USD","LU2063271972.USD","SG9999015986.USD","LU1720051108.HKD","LU0786609619.USD","LU0320765992.SGD","LU1712237335.SGD","LU1291159041.SGD","BK4588","LU2602419157.SGD","SG9999001176.USD","SG9999014880.SGD","IE00B4R5TH58.HKD","03165","LU1232071149.USD","LU0316494557.USD","SG9999015945.SGD","RHHBY","LU2491050071.SGD","LU2108987350.USD","LU1917777945.USD","LU2462157665.USD","LU0385154629.USD","LU0708995401.HKD","LU0354030438.USD","LU1551013425.SGD","SGXZ57979304.SGD","LU2456880835.USD","BK4581","LU2746668974.SGD","LU2237443978.SGD","SG9999014914.USD","LU0471298777.SGD","LU0823416689.USD","BK4007","LU0323591593.USD","LU2265009873.SGD","LU0006306889.USD"],"gpt_icon":1},{"id":"2569788801","title":"罗氏(RHHBY.US)乳腺癌新药三期试验达主要终点 延长晚期患者无进展生存期","url":"https://stock-news.laohu8.com/highlight/detail?id=2569788801","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2569788801?lang=zh_cn&edition=fundamental","pubTime":"2025-09-22 17:20","pubTimestamp":1758532835,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，瑞士制药商罗氏宣布Giredestrant治疗乳腺癌的III期evERA研究取得了积极结果。Giredestrant帮助患有特定类型晚期乳腺癌的患者延长了疾病未恶化的生存期。该药物能否延长患者生命尚待观察，但罗氏在周一的声明中指出存在\"明显的积极趋势\"。这些结果是罗氏今年计划公布的一系列药物试验数据的一部分，这些数据将决定罗氏未来的竞争力。研究的主要终点是研究者评估的意向治疗人群和ESR1突变亚组的无进展生存期。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1347951.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4007","03165","RHHBY"],"gpt_icon":0},{"id":"2568756421","title":"罗氏(RHHBY.US)将以高达35亿美元收购89bio(ETNB.US) 加码减肥药市场","url":"https://stock-news.laohu8.com/highlight/detail?id=2568756421","media":"智通财经","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568756421?lang=zh_cn&edition=fundamental","pubTime":"2025-09-18 15:28","pubTimestamp":1758180528,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，罗氏将以高达35亿美元的价格收购生物制药公司89bio，这是该瑞士制药商进军减肥药及相关疗法市场的最新举措。罗氏将以每股14.50美元的现金收购89bio，股权总价值约为24亿美元。罗氏计划加快其实验性减肥药物的研发进程，这些药物在较小规模的试验中取得的数据好坏参半，但目前正朝着临床开发的关键最后阶段迈进。罗氏近期最大的几笔交易都与肥胖症相关。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1346733.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["ETNB","BK4585","RHHBY","BK4007","BK4139","03165"],"gpt_icon":0}],"pageSize":4,"totalPage":4,"pageCount":1,"totalSize":14,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/RHHBY\",params:#limit:6,delay:false,,,undefined,":[]}}